JP2011510120A5 - - Google Patents

Download PDF

Info

Publication number
JP2011510120A5
JP2011510120A5 JP2010542410A JP2010542410A JP2011510120A5 JP 2011510120 A5 JP2011510120 A5 JP 2011510120A5 JP 2010542410 A JP2010542410 A JP 2010542410A JP 2010542410 A JP2010542410 A JP 2010542410A JP 2011510120 A5 JP2011510120 A5 JP 2011510120A5
Authority
JP
Japan
Prior art keywords
group
substituted
functional group
unsubstituted
moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010542410A
Other languages
English (en)
Japanese (ja)
Other versions
JP5514736B2 (ja
JP2011510120A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/030762 external-priority patent/WO2009089542A2/en
Publication of JP2011510120A publication Critical patent/JP2011510120A/ja
Publication of JP2011510120A5 publication Critical patent/JP2011510120A5/ja
Application granted granted Critical
Publication of JP5514736B2 publication Critical patent/JP5514736B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010542410A 2008-01-11 2009-01-12 ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物 Active JP5514736B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2068408P 2008-01-11 2008-01-11
US61/020,684 2008-01-11
US2933708P 2008-02-16 2008-02-16
US61/029,337 2008-02-16
PCT/US2009/030762 WO2009089542A2 (en) 2008-01-11 2009-01-12 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

Publications (3)

Publication Number Publication Date
JP2011510120A JP2011510120A (ja) 2011-03-31
JP2011510120A5 true JP2011510120A5 (cg-RX-API-DMAC7.html) 2013-06-27
JP5514736B2 JP5514736B2 (ja) 2014-06-04

Family

ID=40853790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010542410A Active JP5514736B2 (ja) 2008-01-11 2009-01-12 ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物

Country Status (7)

Country Link
US (2) US8110651B2 (cg-RX-API-DMAC7.html)
EP (3) EP2669313B1 (cg-RX-API-DMAC7.html)
JP (1) JP5514736B2 (cg-RX-API-DMAC7.html)
KR (1) KR101486449B1 (cg-RX-API-DMAC7.html)
CN (1) CN101959934B (cg-RX-API-DMAC7.html)
DK (1) DK3042922T3 (cg-RX-API-DMAC7.html)
WO (1) WO2009089542A2 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101706B2 (en) 2008-01-11 2012-01-24 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
US8110651B2 (en) * 2008-01-11 2012-02-07 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
EP2310440A4 (en) * 2008-07-10 2013-06-05 Serina Therapeutics Inc POLYOXAZOLINES WITH INTERNAL END GROUPS, POLYOXAZOLINES MANUFACTURED FROM PROTECTED INITIAL GROUPS AND CORRESPONDING COMPOUNDS
BR112013017140B1 (pt) 2011-01-04 2019-12-17 Bender Analytical Holding Bv polímeros reticulados e implantes provenientes de polioxazolina eletrofilicamente ativada
CN102731791B (zh) * 2011-04-13 2016-04-13 北京大学 温度敏感型嵌段共聚物及其水凝胶和其用途
US20140271527A1 (en) * 2011-11-01 2014-09-18 Serina Therapeutics, Inc. Subcutaneous delivery of polymer conjugates of therapeutic agents
US8383093B1 (en) * 2011-11-01 2013-02-26 Serina Therapeutics, Inc. Subcutaneous delivery of poly(oxazoline) conjugates
BR112014016338B1 (pt) * 2012-01-02 2021-01-26 Universiteit Gent polímeros de polioxazolina e processos para a sua preparação, conjugados destes polímeros e usos médicos dos mesmos
US9416228B2 (en) 2012-03-16 2016-08-16 Bender Analytical Holding B.V. Cross-linked polymers and medical products derived from nucleophilically activated polyoxazoline
US10035822B2 (en) 2012-11-15 2018-07-31 Apellis Pharmaceuticals, Inc. Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
US10071168B2 (en) 2014-07-31 2018-09-11 Serina Therapeutics, Inc. Polyoxazoline antibody drug conjugates
EP3197940B1 (en) 2014-09-26 2023-02-15 Alcon Inc. Polymerizable polysiloxanes with hydrophilic substituents
JP6683398B2 (ja) 2014-10-06 2020-04-22 ガット テクノロジーズ ビー.ブイ.Gatt Technologies B.V. 組織接着性多孔質止血製品
KR20180090785A (ko) 2015-10-07 2018-08-13 아펠리스 파마슈티컬스 인코포레이티드 투여 요법
CN105418911A (zh) * 2015-12-29 2016-03-23 南京工业大学 一种聚(2-r-2-噁唑啉)嵌段聚(肌氨酸)双亲性嵌段共聚物的制备方法
BR112019020955A2 (pt) 2017-04-07 2020-05-05 Apellis Pharmaceuticals, Inc. regimes de dosagem e composições e métodos relacionados
DE102018000650A1 (de) * 2018-01-27 2019-08-01 Friedrich-Schiller-Universität Jena Verfahren zur Bestimmung von Verunreinigungen in Polyalkylenethern oder Polyalkylenaminen und dessen Verwendung
CN120154736A (zh) * 2018-07-27 2025-06-17 塞瑞纳治疗阿拉巴马公司 儿茶酚化合物和水溶性聚合物的可裂解缀合物以及使用它们的治疗方法
US12485181B2 (en) * 2019-06-28 2025-12-02 Serina Therapeutics (Al), Inc. Polyoxazoline-drug conjugates with novel pharmacokinetic properties
CN113354811B (zh) * 2020-02-19 2024-05-07 华东理工大学 一种侧链含有氨基和/或羟基的噁唑啉聚合物,其制备方法及应用
CN112661961B (zh) * 2020-12-28 2022-05-06 中国科学院长春应用化学研究所 两亲性聚噁唑啉共聚物、其制备方法及应用
WO2022173667A1 (en) 2021-02-09 2022-08-18 Serina Therapeutics, Inc. Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same
IL309502A (en) 2021-09-03 2024-02-01 CureVac SE Lipid nanoparticles for nucleic acid delivery involving phosphatidylserine
EP4763287A2 (en) 2021-09-03 2026-06-24 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
KR20230044782A (ko) 2021-09-27 2023-04-04 삼성전자주식회사 패치 안테나를 포함하는 안테나 구조 및 이를 포함하는 전자 장치
EP4422698A1 (en) 2021-10-29 2024-09-04 CureVac SE Improved circular rna for expressing therapeutic proteins
EP4469091A1 (en) 2022-01-28 2024-12-04 CureVac SE Nucleic acid encoded transcription factor inhibitors
KR20250153298A (ko) 2023-03-08 2025-10-24 큐어백 에스이 핵산 전달을 위한 신규의 지질 나노입자 제형
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709039A (en) * 1986-03-21 1987-11-24 The Dow Chemical Company Vinyloxazoline monomer and preparation thereof
WO1990002144A1 (en) 1988-08-22 1990-03-08 Fused Kontacts Of Chicago, Inc. Compositions for making improved gas permeable contact lenses
US5166322A (en) 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5130126A (en) 1990-07-09 1992-07-14 Nippon Oil & Fats Co., Ltd. Polymer-drug conjugate and a method of producing it
US5416071A (en) 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5635571A (en) * 1995-06-30 1997-06-03 Cornell Research Foundation, Inc. Polymerizable macromonomers and polymers prepared therefrom
ATE375363T1 (de) 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
PE20010288A1 (es) 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
CZ299516B6 (cs) 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
DE19936014C2 (de) 1999-08-04 2003-04-03 Zf Lemfoerder Metallwaren Ag Gummilager mit axialer Dämpfung
WO2001076639A2 (en) 2000-04-06 2001-10-18 Pharmacia Corporation Chemically-modified myelopoietin conjugates
US20030191291A1 (en) 2000-09-08 2003-10-09 Kochendoerfer Gerd G. Synthetic erythropoiesis stimulating proteins
AU2001290312A1 (en) 2000-10-16 2002-04-29 Chugai Seiyaku Kabushiki Kaisha Peg-modified erythropoietin
US6759496B2 (en) * 2000-12-18 2004-07-06 Bausch & Lomb Incorporated Poly(2-oxazoline) biomedical devices
AU3323002A (en) 2000-12-20 2002-07-01 Hoffmann La Roche Erythropoietin conjugates
KR100401296B1 (ko) 2000-12-27 2003-10-11 드림바이오젠 주식회사 수식물질에 의해 수식된 단백질 변이체 및 이것의 제조방법
US7077939B1 (en) 2001-06-18 2006-07-18 The Texas A&M University System Method and apparatus for nanoparticle transport and detection
US6908963B2 (en) 2001-10-09 2005-06-21 Nektar Therapeutics Al, Corporation Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
US7125843B2 (en) 2001-10-19 2006-10-24 Neose Technologies, Inc. Glycoconjugates including more than one peptide
JP3984541B2 (ja) * 2001-12-26 2007-10-03 財団法人川村理化学研究所 星型ポリオキサゾリンからなる粒子およびその製造方法
WO2003066069A1 (en) 2002-02-01 2003-08-14 Intradigm Corporation Polymers for delivering peptides and small molecules in vivo
EP1344810A1 (en) 2002-03-13 2003-09-17 Infineum International Limited Fuel additive compositions for diesel engine equipped with a particulate trap
US7074755B2 (en) 2003-05-17 2006-07-11 Centocor, Inc. Erythropoietin conjugate compounds with extended half-lives
WO2004108667A2 (en) 2003-05-30 2004-12-16 Centocor, Inc. Formation of novel erythropoietin conjugates using transglutaminase
PT1512736T (pt) 2003-09-05 2018-05-29 Infineum Int Ltd Composições estabilizadas de aditivos para gasóleo
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
NZ555308A (en) 2004-12-22 2010-10-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
WO2007010552A2 (en) 2005-03-17 2007-01-25 Serum Institute Of India Limited N- terminal peg conjugate of erythropoietin
CN106046370A (zh) 2007-02-28 2016-10-26 塞瑞纳治疗公司 聚噁唑啉poz化合物、合成其的方法、以及靶分子‑poz偶联物
US8110651B2 (en) * 2008-01-11 2012-02-07 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
US8101706B2 (en) * 2008-01-11 2012-01-24 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

Similar Documents

Publication Publication Date Title
Jäger et al. Branched and linear poly (ethylene imine)-based conjugates: synthetic modification, characterization, and application
Das et al. Activated ester containing polymers: opportunities and challenges for the design of functional macromolecules
JP5312050B2 (ja) 分割型の分解性重合体とそれから生成される複合体
Yang et al. Synthesis of multifunctional polymers through the Ugi reaction for protein conjugation
CA2824093C (en) Polymeric prodrug with a self-immolative linker
Hall et al. Synthesis and post‐polymerization modification of maleimide‐containing polymers by ‘thiol‐ene’click and Diels–Alder chemistries
EP1926768B1 (en) Branched functionalized polymers using branched polyol cores
Stenzel Bioconjugation using thiols: old chemistry rediscovered to connect polymers with nature’s building blocks
Li et al. Multifunctional photodegradable polymers for reactive micropatterns
Schönemann et al. Sulfobetaine methacrylate polymers of unconventional polyzwitterion architecture and their antifouling properties
Tao et al. Branched polymer− protein conjugates made from mid-chain-functional P (HPMA)
JP5514736B2 (ja) ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物
JP2011174077A (ja) 脂肪族生物分解性リンカーに基づく放出可能なポリマー複合体
CN101835496A (zh) 靶向羟基磷灰石的多臂聚合物以及由其制造的偶联物
Lin et al. Protein–polymer conjugation via ligand affinity and photoactivation of glutathione S-transferase
Choi et al. Functionalized N-Heterocyclic Carbene Monolayers on Gold for Surface-Initiated Polymerizations
JP2015530451A (ja) ポリマー基板にコーティングを適用するための方法
He et al. Postpolymerization modification using less cytotoxic activated ester polymers for the synthesis of biological active polymers
Heo et al. Structural modifications on dopamine molecules toward polydopamine applications
RU2017103462A (ru) Материалы и способы, связанные с линкерами для применения в конъюгатах лекарственного средства и белка
US6468522B1 (en) Controlled release of thioamide moiety-containing therapeutic agents
KR20220069994A (ko) 비대칭 분기형 분해성 폴리에틸렌글리콜 유도체
CN113677736B (zh) 分支型分解性聚乙二醇衍生物
JP2008304427A (ja) バイオデバイスおよびその製造方法、並びにバイオセンサー
KR102668424B1 (ko) 분해성 폴리에틸렌글리콜 유도체